4-(1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-(6-methylpyridin-2-yl)-1H-imidazol-4-yl)benzamide

ID: ALA562347

Chembl Id: CHEMBL562347

PubChem CID: 23658357

Max Phase: Preclinical

Molecular Formula: C24H20N4O3

Molecular Weight: 412.45

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cccc(-c2nc(-c3ccc(C(N)=O)cc3)cn2-c2ccc3c(c2)OCCO3)n1

Standard InChI:  InChI=1S/C24H20N4O3/c1-15-3-2-4-19(26-15)24-27-20(16-5-7-17(8-6-16)23(25)29)14-28(24)18-9-10-21-22(13-18)31-12-11-30-21/h2-10,13-14H,11-12H2,1H3,(H2,25,29)

Standard InChI Key:  KZGNXQHWFYBBCK-UHFFFAOYSA-N

Associated Targets(Human)

TGFBR1 Tchem TGF-beta receptor type I (3786 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACVR1B Tchem Activin receptor type-1B (1131 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACVR1C Tbio Activin receptor type-1C (35 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 412.45Molecular Weight (Monoisotopic): 412.1535AlogP: 3.78#Rotatable Bonds: 4
Polar Surface Area: 92.26Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 1.89CX LogP: 3.46CX LogD: 3.46
Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.55Np Likeness Score: -1.30

References

1. Li X, Wang L, Long L, Xiao J, Hu Y, Li S..  (2009)  Synthesis and biological evaluation of 1,2,4-trisubstituted imidazoles and 1,3,5-trisubstituted pyrazoles as inhibitors of transforming growth factor beta type 1 receptor (ALK5).,  19  (16): [PMID:19616940] [10.1016/j.bmcl.2009.04.066]

Source